Autografting for B2 Glenoids

Conjunctival Z-plasty for Pterygium: Comparison with Conjunctival Autografting

Pterygium is an abnormal overgrowth of the conjunctiva onto the cornea. Surgical management is the choice of treatment when persistent discomfort, visual distortion, and restricted ocular motility bothers patient’s life.1 Although an easy procedure, the main problem with the surgical excision of the pterygium is the recurrence rate, which can be as high as 30 to 82% (1-3). Recurrence is usually...

Autografting as first line treatment for chronic myeloid leukaemia.

Interest in autografting for chronic myeloid leukaemia and its clinical relevance has revived in recent years. This followed observations that with various chemotherapeutic regimens it was possible to achieve, temporarily at least, peripheral blood and bone marrow that were Philadelphia negative. Bone marrow or peripheral blood progenitor cells could then be harvested and reinfused following a ...

The role of autografting in lymphoma.

Leaders Autografting as first line treatment for chronic myeloid leukaemia

Interest in autografting for chronic myeloid leukaemia and its clinical relevance has revived in recent years. This followed observations that with various chemotherapeutic regimens it was possible to achieve, temporarily at least, peripheral blood and bone marrow that were Philadelphia negative. Bone marrow or peripheral blood progenitor cells could then be harvested and reinfused following a ...

Busulfan alone as cytoreduction before autografting for chronic myelogenous leukemia.

A number of prospective randomized studies have recently been designed to address the question of whether autografting prolongs survival for patients with chronic myelogenous leukemia (CML) in chronic phase,1,2 but there is no general agreement as to the optimal approach to cytoreduction before transfusion of autologous stem cells. We believe that the use of high-dose busulfan alone, as used in...